Geriatric and Oncological Evaluation With Technology for Holistic Healthcare Management for Older… (NCT05423808) | Clinical Trial Compass
WithdrawnNot Applicable
Geriatric and Oncological Evaluation With Technology for Holistic Healthcare Management for Older Multimorbid Patients.
Stopped: important delays in digital health tool development made the timelines unfeasible within the project
Belgium0Started 2024-06
Plain-language summary
The GerOnTe TWOBE study aims to evaluate the effectiveness of the GerOnTe intervention, consisting of a renewed, patient-centred, care pathway coordinated by an APN and supported by a Health Professional Consortium and IC Technology, compared to the current standard of care in the eight different Belgian and Dutch hospitals.
Who can participate
Age range70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Age ≥ 70 years old,
✓. New or progressive cancer (breast, lung, colorectal, prostate) fulfilling the tumour specific inclusion criteria,
✓. Estimated life expectancy greater than 6 months,
✓. At least one moderate/severe multimorbidity inclusion criteria other than current cancer (separate list),
✓. Patients must be willing and able to comply with study procedures,
✓. Voluntarily signed and dated written informed consents prior to any study specific procedure,
✓. QLQ-C30 Quality of Life Questionnaire fully completed at baseline, before inclusion.
✓0.2. Metastatic lung cancer (M1):
Exclusion criteria
✕. Mental illness/cognitive impairment that limits ability to provide consent or complete trial procedures.
✕. Participating to an interventional clinical trial with a non-registered anticancer drug or to another geriatric intervention trial.
✕. Patients and caregivers are unable or unwilling to use ICT-devices (tablet, computer, smartphone) or the Internet according to protocol.